Endo International Stock Analysis (NASDAQ:ENDP)

Add to My Stocks
$12.34 $0.56 (4.34%) ENDP stock closing price Jan 20, 2017 (Closing)
Watch Robo Advisor Video of ENDP Stock Analysis
Endo International
Updated on : Jan 20, 2017
previous close
ENDP 12.3 (0%)
S&P 500 2271.3 (0%)
Closing Price On: Jan 20, 2017
stock rating
RATING: ★★★★★★★★★★ (0/5)
Industry :
Medical-Drugs
Sector :
Medical
5 Quarter Revenue
Revenue Growth
2016-Q3
$million
%
YOY GROWTH
Compared to the industry
Long Term Growth
5 Year CAGR:
9.5%
Operating Profit
Operating Margin:
-9.9%
Sector Average:
-1.3%
5 Quarter Net Profit
Net Margins
2016-Q3
%
LTM Margin
Debt/Equity Ratio
Debt:
8.29B
Debt/Equity Ratio:
 1.37
Compared to the industry
Cash Flow
Operating cash flow:
-$111.3M
Net Income:
-$218.9M
PROS      CONS
PE Valuation
PS Valuation
Long Term Growth
Operating Margins
Net Margins
High Debt Burden
ROE
FCF Margin
Rating: ★★★★★★★★★★ (0/5)
Relative Valuation
ENDP PS :
0.7
Industry PS :
4.4
Sector:   Medical.   *PE adjusted for one time items.
Other Metrics
Return on Invested Capital:
1.7%
Return on Equity:
-2.1%
Free Cash Flow Margin:
-16.5%
Double Tap To Exit Full Screen
0:00
/

Endo International Analysis Video

229 6 2

View Endo International stock analysis video. This is our ENDP analyst opinion covering the buy and sell arguments for ENDP stock.

Endo International plc - Ordinary Shares Stock Rating (2.5/5)

Our Endo International stock opinion is based on fundamentals of the company. This Endo International stock analysis is based on latest Q3 earnings for 2016. The stock price analysis takes into account a company's valuation metrics.

Should you buy ENDP stock?

  • ENDP stock is trading at an earnings multiple of 2.9 which is better than the industry average of 21.9.
  • ENDP stock is trading at a favorable price to sales multiple of 0.7 as against the Medical-Drugs industry average multiple of 4.4.

Should you sell ENDP stock?

  • Over the last 5 years, the company registered a poor revenue growth of .
  • Endo International registered a negative operating margin of -9.9% (average) over the Trailing Twelve Months (TTM).
  • Over the last 12 months, Endo International had an average Net loss of -3.3%.
  • Endo International is debt laden and has a high debt/equity ratio of  1.37.
  • Endo International has a negative ROE (Return On Equity) of -2.1%, indicating the company is not profitable.
  • Endo International has a negative FCF (Free Cash Flow) margin of -16.5%.

Comments on this video and Endo International stock